• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在人神经母细胞瘤细胞系中对编码两种蛋白产物异构体的原癌基因ret信使核糖核酸的特性分析。

Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.

作者信息

Tahira T, Ishizaka Y, Itoh F, Sugimura T, Nagao M

机构信息

Carcinogenesis Division, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Oncogene. 1990 Jan;5(1):97-102.

PMID:2181380
Abstract

The ret proto-oncogene expresses four major mRNA species of different lengths in human malignant cell lines and rat tissues. We isolated ret proto-oncogene cDNA clones from a cDNA library of a human neuroblastoma line, Nagai, which over-expressed these mRNAs. Four cDNA clones differing from each other in their 3' portions were analysed. The sequence of the region common to the cDNA clones is essentially identical to a reported cDNA sequence derived from THP-1 monocytic leukemia cells, that encodes a protein with characteristic features of receptor-type tyrosine kinase. From the 3' heterogeneity, two isoforms of the ret proto-oncogene product of 1072 and 1114 residues that differed from each other in their 9 and 51 C-terminal amino acids are predicted. Comparison of the structures of cDNA clones with that of the genomic clone showed that the 3' heterogeneity is produced by alternative polyadenylation and splicing of mRNA. Northern blot analysis using various fragments of cDNA indicated that the 4.5 kb, 3.9 kb and possibly 7.0 kb transcripts may encode a protein of 1072 residues, while the 6.0 kb transcript and a (minor) 4.6 kb transcript may encode a protein of 1114 residues.

摘要

原癌基因ret在人恶性细胞系和大鼠组织中表达四种不同长度的主要mRNA种类。我们从人神经母细胞瘤系Nagai的cDNA文库中分离出ret原癌基因cDNA克隆,该细胞系过度表达这些mRNA。对在其3'部分彼此不同的四个cDNA克隆进行了分析。cDNA克隆共有的区域序列与源自THP-1单核细胞白血病细胞的报道cDNA序列基本相同,该序列编码具有受体型酪氨酸激酶特征的蛋白质。根据3'异质性,预测了ret原癌基因产物的两种异构体,分别为1072个和1114个残基,它们在9个和51个C末端氨基酸上彼此不同。将cDNA克隆的结构与基因组克隆的结构进行比较表明,3'异质性是由mRNA的可变聚腺苷酸化和剪接产生的。使用cDNA的各种片段进行的Northern印迹分析表明,4.5kb、3.9kb以及可能的7.0kb转录本可能编码一个1072个残基的蛋白质,而6.0kb转录本和一个(少量的)4.6kb转录本可能编码一个1114个残基的蛋白质。

相似文献

1
Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line.在人神经母细胞瘤细胞系中对编码两种蛋白产物异构体的原癌基因ret信使核糖核酸的特性分析。
Oncogene. 1990 Jan;5(1):97-102.
2
Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.编码具有两个潜在跨膜结构域的酪氨酸激酶的原癌基因ret的克隆与表达。
Oncogene. 1988 Nov;3(5):571-8.
3
Specific expression of the ret proto-oncogene in human neuroblastoma cell lines.原癌基因ret在人神经母细胞瘤细胞系中的特异性表达。
Oncogene. 1990 Sep;5(9):1291-6.
4
Characterization of RET proto-oncogene 3' splicing variants and polyadenylation sites: a novel C-terminus for RET.RET原癌基因3'剪接变体和聚腺苷酸化位点的特征:RET的一种新型C末端
Oncogene. 1995 Nov 16;11(10):2039-45.
5
Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells.在神经母细胞瘤和白血病细胞中鉴定原癌基因ret的产物。
Oncogene. 1991 Feb;6(2):297-301.
6
Presence of aberrant transcripts of ret proto-oncogene in a human papillary thyroid carcinoma cell line.人甲状腺乳头状癌细胞系中ret原癌基因异常转录本的存在。
Jpn J Cancer Res. 1989 Dec;80(12):1149-52. doi: 10.1111/j.1349-7006.1989.tb01645.x.
7
Identification and analysis of the ret proto-oncogene promoter region in neuroblastoma cell lines and medullary thyroid carcinomas from MEN2A patients.在神经母细胞瘤细胞系及MEN2A患者的甲状腺髓样癌中对ret原癌基因启动子区域的鉴定与分析。
Oncogene. 1992 Jun;7(6):1201-6.
8
cDNA cloning of mouse ret proto-oncogene and its sequence similarity to the cadherin superfamily.小鼠原癌基因ret的cDNA克隆及其与钙黏蛋白超家族的序列相似性。
Oncogene. 1993 Apr;8(4):1087-91.
9
Multiple mRNA isoforms of the human RET proto-oncogene generated by alternate splicing.
Oncogene. 1995 Apr 6;10(7):1377-83.
10
Isolation of ret proto-oncogene cDNA with an amino-terminal signal sequence.分离具有氨基末端信号序列的ret原癌基因cDNA。
Oncogene. 1989 Jun;4(6):805-6.

引用本文的文献

1
Molecular Genetics of Pheochromocytoma/Paraganglioma.嗜铬细胞瘤/副神经节瘤的分子遗传学
Curr Opin Endocr Metab Res. 2024 Sep;36. doi: 10.1016/j.coemr.2024.100527. Epub 2024 May 31.
2
TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation.TMEM127 通过促进 RET 泛素化、定位和降解来抑制肿瘤的发展。
Cell Rep. 2023 Sep 26;42(9):113070. doi: 10.1016/j.celrep.2023.113070. Epub 2023 Sep 1.
3
Research in the genetics of pheochromocytoma and paraganglioma: a bibliometric analysis from 2002 to 2022.
嗜铬细胞瘤和副神经节瘤的遗传学研究:2002年至2022年的文献计量分析
Clin Exp Med. 2023 Nov;23(7):3969-3980. doi: 10.1007/s10238-023-01049-6. Epub 2023 Apr 27.
4
RET aberrant cancers and RET inhibitor therapies: Current state-of-the-art and future perspectives.RET 异常致癌与 RET 抑制剂治疗:现状与未来展望。
Pharmacol Ther. 2023 Feb;242:108344. doi: 10.1016/j.pharmthera.2023.108344. Epub 2023 Jan 9.
5
The Emerging Portrait of Glial Cell Line-derived Neurotrophic Factor Family Receptor Alpha (GFRα) in Cancers.胶质细胞系衍生的神经营养因子家族受体 α 在癌症中的新兴特征。
Int J Med Sci. 2022 Mar 28;19(4):659-668. doi: 10.7150/ijms.64133. eCollection 2022.
6
Higher Gene Expression Levels Do Not Represent anAlternative Activation Mechanism in Medullary Thyroid Carcinoma.高基因表达水平并不代表甲状腺髓样癌的另一种激活机制。
Biomolecules. 2021 Oct 19;11(10):1542. doi: 10.3390/biom11101542.
7
Targeting Rearranged during Transfection in Cancer: A Perspective on Small-Molecule Inhibitors and Their Clinical Development.靶向转染过程中的重排肿瘤:小分子抑制剂及其临床开发的新视角。
J Med Chem. 2021 Aug 26;64(16):11747-11773. doi: 10.1021/acs.jmedchem.0c02167. Epub 2021 Aug 17.
8
Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma.胰腺导管腺癌的周围神经侵犯的细胞和分子机制。
Cancer Commun (Lond). 2021 Aug;41(8):642-660. doi: 10.1002/cac2.12188. Epub 2021 Jul 15.
9
Roles of the Proto-oncogene in Cancer and Development.原癌基因在癌症与发育中的作用。
JMA J. 2020 Jul 15;3(3):175-181. doi: 10.31662/jmaj.2020-0021. Epub 2020 Jul 7.
10
RET Receptor Tyrosine Kinase: Role in Neurodegeneration, Obesity, and Cancer.RET 受体酪氨酸激酶:在神经退行性变、肥胖和癌症中的作用。
Int J Mol Sci. 2020 Sep 26;21(19):7108. doi: 10.3390/ijms21197108.